2BB score and signals
ArriVent BioPharma, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 17 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 5 | Very Low |
Company facts
| Headquarters | Newtown Square, Pennsylvania, United States |
| Founded | 2021 |
| Employees | 77 |
| 52-week range | $16.10 – $35.83 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -1.0409 | — | $0.00 |
| 2026-08-18 | — | -1.0071 | — | $0.00 |
| 2026-05-11 | — | -0.9125 | — | $0.00 |
| 2026-03-01 | — | -0.8643 | — | $0.00 |
2BBBullish & Bearish